Bisphosphonate-induced osteonecrosis of the jaw: Long-term outcomes

Journal of Supportive Oncology

Volumn 7, Issue 1, 2009, Pages 9-10

  Dickerson, Laura ^a   Moreb, Jan S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; MOUTHWASH; OXYGEN; PAMIDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ADULT; ANTIBIOTIC THERAPY; BONE METASTASIS; BONE PAIN; BONE SWELLING; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DEBRIDEMENT; DENTAL SURGERY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERBARIC OXYGEN; JAW OSTEONECROSIS; JAW PAIN; LETTER; MALE; MOUTH DISCOMFORT; MOUTH DISEASE; MOUTH DYSFUNCTION; MOUTH HYGIENE; MULTIPLE MYELOMA; PATIENT SATISFACTION; QUALITY OF LIFE; SEQUESTROTOMY; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT RESPONSE; BONE NECROSIS; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; JAW DISEASE; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEONECROSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 64849102003     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Kyle RA, Yee GC, Somerfield MR, et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol 2007;25:2464-2472.
2. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:433-441.
3. Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 2008;44:857-869.
4. Freiberger JJ, Padilla-Burgos R, Chhoeu AH, et al. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 2007;65:1321-1327.
5. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567-1575.
6. Hoff AO, Toth BB, Altundag K, et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 2008;23:826-836.
7. La Verde N, Bareggi C, Garassino M, et al. Osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates: how the knowledge of a phenomenon can change its evolution. Support Care Cancer 2008;16:1311-1315.
8. Tosi P, Zamagni E, Cangini D, et al. Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone. Blood 2006;108:3951-3952.